Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: John Bloxom who wrote (872)	5/7/1998 8:22:00 PM
From: Michael Greene	Read Replies (2) \| Respond to of 2135

>>My guess is that Dr. Folkman is not well-versed in the legalese applicable to these matters and that in his efforts to quell this week's exuberance, he simply mis-spoke. That is the read of others closer to the company than me as well. John, thanks for the response. This makes sense to me. The 10K seems to be pretty clear, EntreMed is in a strong position regarding rights to the developments from Dr. Folkman's lab. I was also pleased to see in the Bloomberg article that ENMD now has a process capable of making enough of the drugs to support human testing. Let me also second your comments on the recent change to the character of this thread. Hopefully, things will settle down and the day traders will chase off after the next hot story. regards, Michael